Ladder Health’s seed round was led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, 25madison Health, Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital and 7Rock Ventures. The post Startup Raises $7M for Virtual-First Pediatric Therapy Model appeared first on MedCity News.
Organizations that are experiencing significant improvements related to AI are not necessarily using more advanced tools. They are just using the tools they have with more intention. The post Why Healthcare AI is Missing the Point appeared first on MedCity News.
Providers don’t need to endorse ibogaine treatment to take this moment seriously. They need to understand it, respect the risk, and prepare for those already seeking it. The post Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers appeared first on MedCity News.
This is not an abstract discussion. It is about sustaining the organizations, employees, and communities that depend on us. If we fail to account for how these policies interact in the real world, we risk weakening the very system we are trying to improve. The post Washington’s Medical Debt Push Risks Missing the Bigger Healthcare…
Appeals and grievances reflect how well a health plan functions under pressure. They also show how effectively your organization can surface, prioritize, and resolve the cases that matter most. The post Why So Few Appeals Happen and What That Reveals About Health Plans appeared first on MedCity News.
Apogee Therapeutics brings AbbVie a long-acting antibody ready for Phase 3 testing in atopic dermatitis, also called eczema. This therapy’s pipeline in a product potential includes respiratory conditions such as asthma — as a monotherapy and as part of novel drug combinations. The post AbbVie’s $11B Apogee Acquisition Brings an Eczema Drug With an Edge…
Eli Lilly made good on its threat to withhold 340B drug discounts from hospitals that refused to submit claims data. Hospital groups are calling the policy unlawful, arguing that the company has no legal authority to create its own compliance requirements for a federal program. The post Hospitals Cry Foul After Eli Lilly Withholds 340B…
Abarca Health and LucyRx plan to combine to build a larger independent PBM serving more than 9 million members. The post Abarca Health and LucyRx to Combine to Scale Independent PBM Model appeared first on MedCity News.
Alternative health plan designs represent much more than a passing trend. They are actively testing long-standing assumptions about how benefits should be structured, delivered, and experienced. The post Alternative Health Plan Designs Are Reshaping Employer Benefits appeared first on MedCity News.
For governments and health systems, monoclonal antibodies represent not just another drug class, but a strategic shift toward precision prevention. The post Passive Immunization: The Expanding Role of Monoclonal Antibodies in Preventive Medicine appeared first on MedCity News.